Skip to main content

Month: July 2022

Medical Marijuana, Inc. Subsidiary Kannaway® Achieves Largest Revenue Month in Company History for Japan Division in June 2022

SAN DIEGO, CA, July 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that in June its subsidiary Kannaway® has achieved its largest revenue month in the Company’s history for its Japan division.  Kannaway® established operations in Japan in 2019 and the company has experienced rapid growth in 2020, 2021 and to date in 2022. Japan’s CBD market is projected to become the second-largest CBD market in Asia, growing to about $1.9 billion USD by 2024. “This year has been phenomenal for Kannaway in Japan. The company has increased sales every month in 2022 so far and we look forward to continuing this...

Continue reading

AvePoint Strengthens Security and Streamlines IT Operations for the Modern Workplace

Company’s latest cloud platform release addresses growing demand for multi-SaaS solutions helping make businesses more productive, compliant and secure JERSEY CITY, N.J., July 12, 2022 (GLOBE NEWSWIRE) — AvePoint (NASDAQ: AVPT), the most advanced SaaS and data management platform provider, today announced enhancements across its cloud platform helping organizations improve security across multiple SaaS applications and scale their IT operations. The improvements reflect AvePoint’s ongoing commitment to helping organizations speed modernization of the applications, technologies and skills that enhance the digital employee experience. “As companies around the world continue to future-proof their businesses, it’s essential they have the solutions necessary to secure their collaboration data and ensure business continuity so that the...

Continue reading

Heritage Bank of Commerce Hires Jan Coonley as Chief People and Diversity Officer

Talented Industry Veteran Brings Extensive Human Resources ExperienceJan Coonley Heritage Bank of Commerce Chief People and Diversity OfficerSAN JOSE, Calif., July 12, 2022 (GLOBE NEWSWIRE) — Heritage Bank of Commerce (the “Bank”), a subsidiary of Heritage Commerce Corp (Nasdaq: HTBK), today announced the appointment of Jan Coonley, SPHR, as Executive Vice President, Chief People and Diversity Officer, effective immediately. With 20 years of experience in Human Resources (“HR”) for the financial services industry, Ms. Coonley will be responsible for overseeing the HR organization and driving people initiatives to cultivate an inclusive culture that supports the Bank’s mission to be the premier community business bank in the San Francisco Bay Area. She will focus on all aspects of HR including compensation and benefits management,...

Continue reading

HP Announces Amendment and Extension of Exchange Offer and Consent Solicitation for Plantronics Notes

PALO ALTO, Calif., July 12, 2022 (GLOBE NEWSWIRE) — HP Inc. (NYSE: HPQ) (“HP” or the “Company”) announced today the amendment and extension of (i) its previously announced private exchange offer to certain eligible holders (the “Exchange Offer”) for any and all outstanding notes (the “Poly Notes”) issued by Plantronics, Inc. (NYSE: POLY) (“Poly”) for up to $500,000,000 aggregate principal amount of new notes to be issued by the Company (the “HP Notes”) and cash, and (ii) the concurrent consent solicitation (the “Consent Solicitation” and, together with the Exchange Offer, the “Exchange Offer and Consent Solicitation”) to adopt certain proposed amendments to the indenture governing the Poly Notes (the “Poly Indenture” and such proposed amendments, the “Proposed Amendments”). HP has (i) extended the Early Participation Date and the...

Continue reading

Invitation to presentation of Scatec ASA’s second quarter results 2022

Oslo, 12 July 2022: Scatec ASA will release its second quarter and first half results on Tuesday 26 July 2022 at 07:00 am (CEST). A presentation of the results followed by a Q&A session will be held on the same day at 09:00 am at Scatec’s headquarters at Skøyen Atrium III (1st floor), Askekroken 11, 0277 Oslo. The presentation and the Q&A session can be followed through a live webcast from our website www.scatec.com, or Scatec Webcast Q2 2022. For further information, please contact:For analysts and investors: Andreas Austrell, VP Investor Relations, ir@scatec.com For media: Stian Karlsen, Communications Manager, stian.karlsen@scatec.com About ScatecScatec is a leading renewable energy solutions provider, accelerating access to reliable and affordable clean energy in high growth markets. As a long-term player, we develop, build,...

Continue reading

Imperial Mining Increases Scandium and Rare Earth Recoveries on Its Crater Lake Development Project, Quebec

MONTREAL, July 12, 2022 (GLOBE NEWSWIRE) — Imperial Mining Group Ltd. (“Imperial”) (TSX VENTURE: IPG; OTCQB: IMPNF) is pleased to announce that early results from the previously-announce process flowsheet optimization work show significantly improved scandium and rare earth recoveries relative to previous reported results. In addition, exploration crews have now mobilized to the Crater Lake property to commence planned summer work. METALLURGICAL PROCESS DEVELOPMENT UPDATE Imperial is currently undertaking a hydrometallurgical flowsheet optimization development program. The optimization work is based on its patent-pending (US Patent and Trademark Office provisional application #63/265,176) two-stage hydrometallurgical method for the extraction of scandium and rare earth elements with SGS Canada. The program is partially...

Continue reading

Processa Pharmaceuticals to Present at the World Orphan Drug Congress USA, July 11-13, 2022

HANOVER, MD., July 12, 2022 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical stage biopharmaceutical company developing drugs to improve the survival and/or quality of life for patients who have unmet medical conditions announced today that Dr. David Young, it’s Chief Executive Officer, will present “Thinking Regulatory First – Considerations for the Effective Development of Rare Disease Therapies” at the World Orphan Drug Congress USA 2022 Conference on Wednesday, July 13, 2022 at 3:25 pm EDT. “The Processa team has successfully developed a number of drugs over the last 30 years with over 30 FDA approvals, some in Orphan indications.” Said Dr. David Young, CEO. “For example, while at Questcor, this team was able to successfully obtain the FDA...

Continue reading

Kindig Academy at Lincoln Tech to Offer Hands-On Weekend Courses for Auto Enthusiasts

Students to learn the fundamental skills of custom auto design and fabrication Parsippany, NJ, July 12, 2022 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (NASDAQ: LINC), a national leader in specialized technical training for more than 75 years, will launch a new series of introductory hands-on training courses at the Kindig Academy at Lincoln Tech in Denver. The shorter weekend courses will complement the school’s  comprehensive six-week Custom Design and Fabrication program by offering “no experience necessary” classes for students interested in building skills for the automotive customization and repair industries starting July 23rd. With more than 150,000 openings projected for skilled, trained collision repair and refinishing professionals across the country by 2030, the Kindig Academy’s convenient weekend courses...

Continue reading

Allogene Therapeutics Appoints Scientific Pioneer Stephen Mayo to its Board of Directors

SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced the appointment of Stephen L. Mayo, Ph.D., a world renowned expert in computational protein design, to the company’s Board of Directors. “We are privileged to have Dr. Mayo join our Board of Directors,” said David Chang, M.D., Ph.D., President, CEO and Co-Founder of Allogene Therapeutics. “His decades-long success record in both academia and the biopharmaceutical industry will serve Allogene well as we look to progress our pipeline of investigational AlloCAR T products to deliver readily available cell therapy faster, more reliably, and at greater scale to more patients.” Dr. Mayo is the Bren...

Continue reading

Hamilton Thorne Appoints Francesco Fragasso as CFO

BEVERLY, Mass. and TORONTO, July 12, 2022 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced the appointment of Francesco Fragasso as Chief Financial Officer, effective on or about September 1, 2022. Michael Bruns will retire as CFO on that date. “We are delighted to have Francesco join us as our CFO,” said David Wolf, President and Chief Executive Officer. “As Hamilton Thorne enters a new stage of growth, we welcome the opportunity to add individuals with operational experience at larger and more diverse organizations to our team. I look forward to working closely with Francesco as Hamilton Thorne continues growing its business.” Mr. Fragasso currently...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.